Atlas Trials

Study of Adverse Renal Effects of Immune Checkpoints Inhibitors

Clinical trial NCT03316417 · COMPLETED

Trial details

NCT number
NCT03316417
Sponsor
Hospices Civils de Lyon
Status
COMPLETED
Study type
OBSERVATIONAL
Adverse EffectRenal Toxicity
Start date
2017-10-27
Primary completion
2017-10-27
Enrollment
353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.